Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Tenner KS"'
1
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
Autor: Carter JM; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada., Chumsri S; Department of Medicine, Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA., Hinerfeld DA; Ultima Genomics, Newark, CA, USA., Ma Y; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA., Wang X; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA., Zahrieh D; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA., Hillman DW; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA., Tenner KS; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA., Kachergus JM; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA., Brauer HA; Bill and Melinda Gates Foundation, Seattle, WA, USA., Warren SE; Kite Pharma, Santa Monica, CA, USA., Henderson D; NanoString Technologies, Inc, Seattle, WA, USA., Shi J; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA., Liu Y; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA., Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Lindman H; Department of Oncology, University of Uppsala, Uppsala, Sweden., Leon-Ferre RA; Department of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Boughey JC; Department of Surgery, Mayo Clinic, Rochester, MN, USA., Liu MC; Natera, Inc, San Carlos, CA, USA., Ingle JN; Department of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Kalari KR; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, FL, USA., Goetz MP; Department of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Perez EA; Department of Medicine, Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA., Thompson EA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. thompson.aubrey@mayo.edu.
Publikováno v: Nature communications [Nat Commun] 2023 Apr 18; Vol. 14 (1), pp. 2215. Date of Electronic Publication: 2023 Apr 18.
Zobrazit plný text záznamu
5
Akademický článek
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Autor: Haddad TC; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. Haddad.Tufia@mayo.edu., He J; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., O'Sullivan CC; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Chen B; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Northfelt D; Mayo Clinic, Scottsdale, AZ, USA., Dueck AC; Mayo Clinic, Scottsdale, AZ, USA., Ballman KV; Weill Cornell Medical College, New York, NY, USA., Tenner KS; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Linden H; Seattle Cancer Care Alliance, Seattle, WA, USA., Sparano JA; Montefiore Medical Center, Bronx, NY, USA., Hopkins JO; Southeast Clinical Oncology Research (SCOR) Consortium, Winston-Salem, NC, USA., De Silva C; Kaiser Permanente-Rock Creek, Lafayette, CO, USA., Perez EA; Mayo Clinic, Jacksonville, FL, USA., Haluska P; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Goetz MP; Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jul; Vol. 188 (2), pp. 477-487. Date of Electronic Publication: 2021 Apr 14.
Zobrazit plný text záznamu
6
Akademický článek
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study.
Autor: Vargas CE; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Thorpe CS; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Dueck AC; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, Arizona., Tenner KS; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, Arizona., Davidson NE; Division of Medical Oncology, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, University of Washington, Seattle, Washington., Martino S; The Angeles Clinic and Research Institute, Santa Monica, California., Pisansky TM; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Hwang ES; Department of Surgery, Duke University, Durham, North Carolina., Halyard MY; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Pockaj BA; Department of Surgery, Mayo Clinic, Phoenix, Arizona., Perez EA; Department of Hematology & Oncology, Mayo Clinic, Jacksonville, Florida.
Publikováno v: Cancer [Cancer] 2020 Dec 15; Vol. 126 (24), pp. 5239-5246. Date of Electronic Publication: 2020 Sep 15.
Zobrazit plný text záznamu
7
Akademický článek
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
Autor: Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA., Fox N; Department of Pathology, Medicine and Dermatology, Columbia University Medical Center, New York, NY, 10032, USA., McCarl CA; Department of Pathology, Medicine and Dermatology, Columbia University Medical Center, New York, NY, 10032, USA., Tenner KS; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA., Ballman K; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA., Erskine CL; Department of Immunology, Mayo Clinic, Rochester, MN, 55905, USA., Necela BM; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA., Northfelt D; Department of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, 85259, USA., Tan WW; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Calfa C; Sylvester Cancer Center, University of Miami, Miami, FL, 33136, USA., Pegram M; Department of Medicine, Stanford University, Stanford, CA, 94305, USA., Colon-Otero G; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA., Perez EA; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA. perez.edith@mayo.edu., Clynes R; Department of Pathology, Medicine and Dermatology, Columbia University Medical Center, New York, NY, 10032, USA. rclynes@xencor.com., Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, FL, 32224, USA. knutson.keith@mayo.edu.
Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2018 Jun 14; Vol. 20 (1), pp. 52. Date of Electronic Publication: 2018 Jun 14.
Zobrazit plný text záznamu
8
Akademický článek
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.
Autor: Perez EA; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA.; Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA., Ballman KV; Division of Biostatistics and Bioinformatics, Department of Health Science Research, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA., Mashadi-Hossein A; Nanostring, Inc., Seattle, WA , USA., Tenner KS; Division of Biostatistics and Bioinformatics, Department of Health Science Research, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA., Kachergus JM; Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA., Norton N; Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA., Necela BM; Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA., Carr JM; Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA., Ferree S; Nanostring, Inc., Seattle, WA , USA., Perou CM; Departments of Genetics and Pathology & Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Baehner F; Genonic Health, Inc., Redwood, CA, USA., Cheang MC; Departments of Genetics and Pathology & Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Thompson EA; Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA.
Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2016 Oct 28; Vol. 109 (2). Date of Electronic Publication: 2016 Oct 28 (Print Publication: 2017).
Zobrazit plný text záznamu
9
Akademický článek
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines.
Autor: Shah MV; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Wiktor AE; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Meyer RG; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Tenner KS; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Ballman KV; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Green SJ; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Sukov WR; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Ketterling RP; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Perez EA; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Jenkins RB; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Oct 10; Vol. 34 (29), pp. 3502-3510.
Zobrazit plný text záznamu
10
Akademický článek
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain.
Autor: Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, Florida. knutson.keith@mayo.edu., Clynes R; Division of Hematology and Oncology, Columbia University, New York, New York., Shreeder B; Department of Immunology, Mayo Clinic, Jacksonville, Florida., Yeramian P; Cancer Vaccines and Immune Therapies Program, Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida., Kemp KP; Cancer Vaccines and Immune Therapies Program, Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida., Ballman K; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Tenner KS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Erskine CL; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida., Northfelt D; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona., Tan W; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida., Calfa C; Memorial Hospital, Hollywood, Florida., Pegram M; Stanford University, Stanford, California., Mittendorf EA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Perez EA; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida.
Publikováno v: Cancer research [Cancer Res] 2016 Jul 01; Vol. 76 (13), pp. 3702-10. Date of Electronic Publication: 2016 Apr 20.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje